Ovid Therapeutics Inc. (OVID)
Latest OVID Insider Trades
Margaret A. Alexander - OfficerOpen-market sale$17K- Jeffrey A. Rona - OfficerOpen-market sale$12K
- Charles Ross Carter - Officer
About Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
- NEW YORK, NY
- 23
- 2017
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 180,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
OVID Insider Transactions (Form 4)
2218 Form 4 filings on record, the earliest from Dec 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Charles Ross Carter - Officer | Grant or award | Common Stock | 50,000 |
Recent OVID Form 8-K Filings
5Recent OVID Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jeffrey A. Rona | Affiliated Stockholder | 325,000 | $910K | View on EDGAR | |
| Jeffrey A. Rona | Affiliated Stockholder |
OVID Insider Trading - FAQ
What is the latest insider trade for OVID?
Ovid Therapeutics Inc. (OVID) had 2 insider filings in the last 90 days, with the most recent on 2026-07-08. The full record for OVID runs to 18 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying OVID stock?
No insider purchases of OVID were filed in the last 90 days.
How many insiders are selling OVID stock?
No insider sales of OVID were filed in the last 90 days. 2 sales are on record for this company.
Where can I see OVID SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks OVID Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow OVID insider buys?
Create a free InsiderAlpha account and press Watch on this page to add OVID to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Charles Ross Carter view on EDGAR
- - Anna Greka view on EDGAR
- - Stelios Papadopoulos view on EDGAR
- - Bart Friedman view on EDGAR
- - Kevin Joseph Fitzgerald view on EDGAR
- - Jeremy M. Levin view on EDGAR
- - Margaret A. Alexander view on EDGAR
- - Stelios Papadopoulos view on EDGAR
- - Jeremy M. Levin view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track OVID insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
